Skip to main content
Erschienen in: Archives of Dermatological Research 1/2013

01.01.2013 | Original Paper

c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum

Erschienen in: Archives of Dermatological Research | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Xeroderma pigmentosum is a rare autosomal recessive disease characterized by hypersensitivity to UV light which is due to alterations of the nucleotide excision repair pathway. Eight genes (XPA to XPG and XPV) are responsible for the disease. Among them, the XPC gene is known to be the most mutated in Mediterranean patients. The aim of this study was to determine the frequency of the most common XPC mutation and describe the clinical features of Moroccan patients with xeroderma pigmentosum. Twenty four patients belonging to 21 unrelated Moroccan families and 58 healthy subjects were investigated. After clinical examination, the screening for the c.1643_1644delTG (p.Val548AlafsX25) mutation in the XPC gene was performed by PCR and automated sequencing of exon 9 in all patients and controls. The molecular analysis showed that among the 24 patients, 17 were homozygous for the c.1643_1644delTG mutation and all their tested parents were heterozygous, whereas the others (7 patients) did not carry the mutation. The frequency of this mutation was estimated to be 76.19 % (16/21 families). None of the 58 healthy individuals carried this mutation. In addition, clinical investigation showed that the majority of the patients bearing this mutation have the same clinical features. Our results revealed that the p.Val548AlafsX25 mutation is the major cause (76.19 %) of xeroderma pigmentosum in Moroccan families. This would have an important impact on improving management of patients and their relatives.
Literatur
1.
Zurück zum Zitat Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K et al (2001) Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem 276:18665–18672PubMedCrossRef Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K et al (2001) Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem 276:18665–18672PubMedCrossRef
2.
Zurück zum Zitat Ben Rekaya M, Messaoud O, Talmoudi F, Nouira S, Ouragini H et al (2009) High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet 54:426–429PubMedCrossRef Ben Rekaya M, Messaoud O, Talmoudi F, Nouira S, Ouragini H et al (2009) High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet 54:426–429PubMedCrossRef
3.
Zurück zum Zitat Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ (1998) Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds) The genetic basis of human cancer. McGraw-Hill, New York, pp 245–274 Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ (1998) Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds) The genetic basis of human cancer. McGraw-Hill, New York, pp 245–274
4.
Zurück zum Zitat Bootsma D, Kraemer KH, Cleaver JJ (2001) Hoeijmakers nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. In: Sly W, Valle D, Scriver AB (eds) The metabolic basis of inherited disease. McGraw-Hill Book Co, New York, pp 245–274 Bootsma D, Kraemer KH, Cleaver JJ (2001) Hoeijmakers nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. In: Sly W, Valle D, Scriver AB (eds) The metabolic basis of inherited disease. McGraw-Hill Book Co, New York, pp 245–274
5.
Zurück zum Zitat Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ (2006) Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry 45:14965–14979PubMedCrossRef Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ (2006) Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry 45:14965–14979PubMedCrossRef
6.
Zurück zum Zitat Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A et al (2000) Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 60:1974–1982PubMed Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A et al (2000) Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 60:1974–1982PubMed
7.
Zurück zum Zitat Daya-Grosjean L, James MR, Drougard C, Sarasin A (1987) An immortalized xeroderma pigmentosum, group C, cell line which replicates SV40 shuttle vectors. Mutat Res 183:185–196PubMedCrossRef Daya-Grosjean L, James MR, Drougard C, Sarasin A (1987) An immortalized xeroderma pigmentosum, group C, cell line which replicates SV40 shuttle vectors. Mutat Res 183:185–196PubMedCrossRef
8.
Zurück zum Zitat Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S et al (2001) Melanoma in xeroderma pigmentosum: 12 cases. Ann Dermatol Venereol 128:503–506PubMed Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S et al (2001) Melanoma in xeroderma pigmentosum: 12 cases. Ann Dermatol Venereol 128:503–506PubMed
9.
Zurück zum Zitat Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949–8956PubMedCrossRef Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949–8956PubMedCrossRef
10.
Zurück zum Zitat Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM et al (2006) Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1 % of the Japanese population. Mutat Res 601:171–178PubMedCrossRef Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM et al (2006) Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1 % of the Japanese population. Mutat Res 601:171–178PubMedCrossRef
11.
Zurück zum Zitat Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB et al (2006) Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 27:84–94PubMedCrossRef Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB et al (2006) Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 27:84–94PubMedCrossRef
12.
Zurück zum Zitat Khatri ML, Bemghazil M, Shafi M, Machina A (1999) Xeroderma pigmentosum in Libya. Int J Dermatol 38:520–524PubMedCrossRef Khatri ML, Bemghazil M, Shafi M, Machina A (1999) Xeroderma pigmentosum in Libya. Int J Dermatol 38:520–524PubMedCrossRef
13.
Zurück zum Zitat Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250PubMedCrossRef Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250PubMedCrossRef
14.
Zurück zum Zitat Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85:1101–1111PubMedCrossRef Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85:1101–1111PubMedCrossRef
15.
Zurück zum Zitat Li L, Bales ES, Peterson CA, Legerski RJ (1993) Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 5:413–417PubMedCrossRef Li L, Bales ES, Peterson CA, Legerski RJ (1993) Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 5:413–417PubMedCrossRef
16.
Zurück zum Zitat Maillard O, Solyom S, Naegeli H (2007) An aromatic sensor with aversion to damaged strands confers versatility to DNA repair. PLoS Biol 5:e79PubMedCrossRef Maillard O, Solyom S, Naegeli H (2007) An aromatic sensor with aversion to damaged strands confers versatility to DNA repair. PLoS Biol 5:e79PubMedCrossRef
17.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
18.
Zurück zum Zitat Moriwaki S, Kraemer KH (2001) Xeroderma pigmentosum—bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47–54PubMedCrossRef Moriwaki S, Kraemer KH (2001) Xeroderma pigmentosum—bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47–54PubMedCrossRef
19.
Zurück zum Zitat Moussaid L, Benchikhi H, Boukind EH, Sqalli S, Mouaki N et al (2004) Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients. Ann Dermatol Venereol 131:29–33PubMedCrossRef Moussaid L, Benchikhi H, Boukind EH, Sqalli S, Mouaki N et al (2004) Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients. Ann Dermatol Venereol 131:29–33PubMedCrossRef
20.
Zurück zum Zitat Rezvani HR, Ged C, Bouadjar B, de Verneuil H, Taieb A (2008) Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 15:241–251PubMedCrossRef Rezvani HR, Ged C, Bouadjar B, de Verneuil H, Taieb A (2008) Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 15:241–251PubMedCrossRef
21.
Zurück zum Zitat Rivera-Begeman A, McDaniel LD, Schultz RA, Friedberg EC (2007) A novel XPC pathogenic variant detected in archival material from a patient diagnosed with xeroderma pigmentosum: a case report and review of the genetic variants reported in XPC. DNA Repair (Amst) 6:100–114CrossRef Rivera-Begeman A, McDaniel LD, Schultz RA, Friedberg EC (2007) A novel XPC pathogenic variant detected in archival material from a patient diagnosed with xeroderma pigmentosum: a case report and review of the genetic variants reported in XPC. DNA Repair (Amst) 6:100–114CrossRef
22.
Zurück zum Zitat Sarasin A, Stary A (2007) New insights for understanding the transcription-coupled repair pathway. DNA Repair (Amst) 6:265–269CrossRef Sarasin A, Stary A (2007) New insights for understanding the transcription-coupled repair pathway. DNA Repair (Amst) 6:265–269CrossRef
23.
Zurück zum Zitat Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C et al (2010) A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 130:1537–1542PubMedCrossRef Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C et al (2010) A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 130:1537–1542PubMedCrossRef
24.
Zurück zum Zitat Stary A, Sarasin A (2002) The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84:49–60PubMedCrossRef Stary A, Sarasin A (2002) The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84:49–60PubMedCrossRef
25.
Zurück zum Zitat Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ et al (1998) xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2:223–232PubMedCrossRef Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ et al (1998) xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2:223–232PubMedCrossRef
26.
Zurück zum Zitat Thoms K-M, Kuschal C, Emmert S (2007) Lessons learned from DNA repair defective syndromes. Exp Dermatol 16(6):532–544PubMedCrossRef Thoms K-M, Kuschal C, Emmert S (2007) Lessons learned from DNA repair defective syndromes. Exp Dermatol 16(6):532–544PubMedCrossRef
27.
Zurück zum Zitat Van Steeg H, Kraemer KH (1999) xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 5:86–94PubMedCrossRef Van Steeg H, Kraemer KH (1999) xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 5:86–94PubMedCrossRef
28.
Zurück zum Zitat Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA et al (1991) xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 11:4128–4134PubMed Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA et al (1991) xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 11:4128–4134PubMed
29.
Zurück zum Zitat Zghal M, El-Fekih N, Fazaa B, Fredj M, Zhioua R et al (2005) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 49 Tunisian cases. Tunis Med 83:760–763PubMed Zghal M, El-Fekih N, Fazaa B, Fredj M, Zhioua R et al (2005) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 49 Tunisian cases. Tunis Med 83:760–763PubMed
Metadaten
Titel
c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum
Publikationsdatum
01.01.2013
Erschienen in
Archives of Dermatological Research / Ausgabe 1/2013
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-012-1299-0

Weitere Artikel der Ausgabe 1/2013

Archives of Dermatological Research 1/2013 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.